Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.